Skip to main content
Toggle navigation
Login
Home
Back
Favorite
1
Like
Facebook
Tweet
Session I: Evolving Landscape of Non-Muscle Invasive Bladder Cancer (NMIBC) and Multidisciplinary Care for MIBC
Debate: BCG-Unresponsive CIS in Non-Cystectomy Candidates - Intravesical chemotherapy vs Intravenous Pembrolizumab - INTRAVENOUS PEMBROLIZUMAB
Wednesday, September 28, 2022
10:27 AM – 10:34 AM
Debate Speaker(s)
Ashish Kamat, MD, MBBS
MD Anderson Cancer Center